drugset / Trial / NCT01612260

Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat

NCT01612260 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the effects of Chinese medicine Shensong Yangxin capsule for the chronic cardiac dysfunction complicated with ventricular premature beats.

Timeline

Start
2012-09
Primary completion
2013-08
Completion
2013-12

Outcome

Met primary endpoint

paper SSYX caused a significantly greater decline in the total number of VPCs than the placebo did PMID 28685712 ↗

paper (-2145 ± 2848 vs. -841 ± 3411, P < 0.05). PMID 28685712 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Shensong Yangxin capsule Traditional medicine (herbal / TCM) 4 unknown Oral